RJFSA
BIVV

Raymond James Financial Services Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Raymond James Financial Services Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-13,133
Closed -$708K – 2813
2017
Q4 		$708K Buy
13,133
+232
+2% +$12.7K ﹤0.01% 1503
2017
Q3 		$736K Sell
12,901
-881
-6% -$51.6K ﹤0.01% 1494
2017
Q2 		$829K Sell
13,782
-4,001
-22% -$228K 0.01% 1383
2017
Q1 		$968K Buy
+17,783
New +$876K 0.01% 1204

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Raymond James Financial Services Advisors's BIVV Position: Q1 2018 in Review

Raymond James Financial Services Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 13,133 shares — an estimated $708K sold.

Raymond James Financial Services Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $968K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Raymond James Financial Services Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 13,133 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $708K.
  • Raymond James Financial Services Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Raymond James Financial Services Advisors's Bioverativ Inc. Common Stock position peaked at $968K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2018, filed 16 Apr 2018.